Indira IVF in talks to acquire Sabine in nearly Rs 1,300 crore deal

Benchmarks Nifty22,749.75-3.46FEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return18.32 % Invest NowFEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return8.45 % Invest NowEnter search text:

The Economic Times daily newspaper is available online now. Read Today's Paper Indira IVF in talks to acquire Sabine in nearly Rs 1,300 crore dealBy Reghu Balakrishnan, ET BureauLast Updated: Oct 28, 2026, 01:26:00 AM ISTSynopsis

Indira IVF is considering an acquisition of Sabine Hospital and Research Centre valued at ₹1,200-1,300 crore. Sabine provides a range of fertility and maternal healthcare services across two facilities in Kerala. The deal would strengthen Indira IVF's presence in the fertility treatment sector in India. Sabine is expected to generate a revenue of ₹230-250 crore in FY 27.

Listen to this article in summarized format

Loading...×Mumbai: Indira IVF, India's largest IVF hospital chain, is in discussions to acquire Sabine Hospital and Research Centre, a Kerala-based chain specialising in infertility treatment and mother-and-child care, according to multiple people aware of the development.

The proposed transaction is likely to value CX Partners-owned Sabine at ₹1,200-1,300 crore, said the people. CX Partners had acquired about 54% stake in Sabine in 2024 at a valuation of $100 million (about ₹835 crore).

Indira IVF, backed by Swedish private equity firm EQT Partners, is likely to acquire a 70-75% stake in Sabine, with buying additional stake from the founder.

Investment bank O3 Capital advises CX on its exit plan.

Live Events

You Might Also Like:

360 ONE, TR Capital among buyers eyeing Paper Boat early backers stake

Founded in 2010 by Dr Sabine Sivadasan, Sabine provides healthcare services-including IVF and other fertility treatments, birthing, newborn care and other gynaecological procedures. Sabine Hospital operates two facilities in Kerala, with a total capacity of 300 beds, including 60 neonatal intensive care unit (NICU) beds. The chain conducts more than 6,000 IVF cycles and 3,000 deliveries annually.

Sabine is expected to post a revenue of ₹230-250 crore with an earnings before interest, taxes, depreciation, and amortisation (Ebitda) of ₹70-80 crore in FY 27, added sources.

Indira IVF, which is preparing for a ₹3500-crore initial public offering (IPO), has been on an acquisition spree to strengthen its position in India's fertility treatment market.

You Might Also Like:

GreatWhite brothers settle dispute as Mehul Shah’s family buys Hemang’s 50% stake

Mails sent to CX Partners, EQT Partners and Sabine Hospital did not elicit any responses till the time of going to press.

Over the last few years, Indira IVF made multiple acquisitions in the fertility space. It acquired Kolkata-based IVF and gynaecology network Abha Surgy Healthcare in April this year. In September last year, it acquired Creation Science IVF, which operates Srishti Hospital, to enter Puducherry market. In June 2025, it acquired Banker IVF to expand footprint in Gujarat.

In March, Nova IVF Fertility-the second largest IVF chain in India- marked its entry into Kerala with acquiring a majority stake in Craft Fertility, a leading fertility chain at a valuation of ₹370 crore.

Nova plans to launch 10 centres across the state over the next 3 to 5 years. It is owned by Asia Healthcare Holdings and led by healthcare industry veteran Vishal Bali, with backing from TPG Growth.

Kerala's declining fertility rate, estimated at around 1.35-1.7, is among the key factors driving growing interest from national IVF chains in the state.

In 2023, EQT acquired about 60% majority stake in Indira IVF for about ₹6,000 crore. Indira IVF was founded by Dr Ajay Murdia in 1988. With a nation-wide network spanning 200 centers across India, Indira is claimed to have supported over 2,00,000 successful pregnancies.
Add as a Reliable and Trusted News Source Add Now!
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onIndira IVFSabine Hospital and Research CentreIVF in Indiafertility treatmentCX Partners

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

...moreless
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onIndira IVFSabine Hospital and Research CentreIVF in Indiafertility treatmentCX Partners

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

...morelessContinue reading with one of these options:Limited AccessFreeLogin to get access to some exclusive stories
& personalised newslettersLogin NowUnlimited AccessStarting @ Rs120/monthGet access to exclusive stories, expert opinions &
in-depth stock reportsSubscribe NowET

Unlock Access to All Exclusives with ETPrime FREE TRIAL

15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers

Trial offer expiring in00 : 05 : 00

I'd rather pay ₹2599 now

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Prime Account Detected!

It seems like you're already an ETPrime member with

Login using your ET Prime credentials to enjoy all member benefits

Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.

Unlock ETPrime's Exclusive Stories Today!

Big Price Drop! Flat 40% Off

Student Only OfferAlready a Member? Sign In nowAlready a Member? Sign In nowAlready a Member? Sign In now

Offer Exclusively For You

Save up to Rs. 700/-

ON ET PRIME MEMBERSHIP

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get Flat 40% Off

Then ₹ 1749 for 1 year

Avail Offer

Offer Exclusively For You

ET Prime at ₹ 49 for 1 month

Then ₹ 1749 for 1 year

Avail Offer

Special Offer

Get flat 40% off on ETPrime

Avail OfferAvail OfferClaim NowAlready a Member? Sign In now

Need Assistance?

Connect with an ETPrime expert for personalized support and guidance

+91 9484700004'; }); } if(listing) { var h3 = "You tried reading " + listArr.length + " locked stories in the past " + threshold + " days.", h4 = "Become an ET Prime member and don't miss out on these exclusive stories."; var html = '

' + h3 + '

' + h4 + '

' + listing + '

'; $('#paidSCWidget').html(html); var callback = $('#paidSCWidget').attr('data-callback'); if(callback && window[callback]) { window[callback](); } customDimension.dimension72 += ' | Shown SYFT no Trial_With Missed Paywalled Articles Collection'; } else { _processNormal() } } }); } else { _processNormal(); } } catch (e) { _processNormal(); } }, function () { _processNormal(); }); //console.log('storyCollectionLoad', $); }

What’s Included with

ETPrime Membership

1Exclusive Insights That Matter

Uncover the truth with our investigative stories

Make strategic moves using the real-world case studies

Read industry-specific stories to identify emerging trends

Spot opportunities with
in-depth insights that matter

• Trump temper on H-1B visas is forcing Indians to do these things to stay put in US

  What Adani’s US indictment means for India Inc’s overseas fundraising

• Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.

  Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?

• Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?

  The problem with lab grown diamonds

• Why a falling rupee is a better option for the economy

  A list of top 20 momentum stocks that have delivered massive returns in one year

2Invest Wisely With Smart Market Tools & Investment Ideas

Alpha Trade

Get daily trade ideas from SEBI-registered research analysts.

Investment Ideas

Grow your wealth with stock ideas & sectoral trends.

Stock Reports Plus

All-in-one stock research with Stock Score, peer comparison & key signals.

BigBull Portfolio

Get to know where the market bulls are investing to identify the right stocks.

Stock Analyzer

Check the score based on the company's fundamentals, solvency, growth, risk & ownership to decide the right stocks.

Market Mood

Analyze the market sentiments & identify the trend reversal for strategic decisions.

Stock Talk Live at 9 AM Daily

Ask your stock queries & get assured replies by ET appointed, SEBI registered experts.

3Stay informed anytime, anywhere with ET ePaper

ePaper - Print View

Read the PDF version of ET newspaper. Download & access it offline anytime.

ePaper - Digital View

Read your daily newspaper in Digital View & get it delivered to your inbox everyday.

Wealth Edition

Manage your money efficiently with this weekly money management guide.

TOI ePaper

Read the PDF version of TOI newspaper. Download & access it offline anytime.

Deep Explainers

Explore the In-depth explanation of complex topics for everyday life decisions.

Health+ Stories

Get fitter with daily health insights committed to your well-being.

Personal Finance+ Stories

Manage your wealth better with in-depth insights & updates on finance.

5Enjoy Complimentary Subscriptions From Top Brands

Stream new documentaries from all across the world every day.

Stories you might be interested in